top of page

NuvOx Pharma wins AZBio Fast Lane Award

NuvOx was honored with the AZBIO Fast Lane Award for the company's many achievements in the last 18 months. The award committee noted the company's advancements in clinical trials for brain cancer and stroke, and continued development in pre-clinical stage indications such as heart attack.


Read full story

Recent Posts

See All

NuvOx Receives SPAN Grant to Conduct Late-stage Preclinical Studies of Putative Neuroprotectants Combined with Reperfusion Tucson, AZ, April 17th, 2023 - NuvOx Pharma (NuvOx), a clinical stage biotec

bottom of page